| PERIOD ENDING | 12-Sep-09 | 20-Jun-09 | 28-Mar-09 | 3-Jan-09 | | Total Revenue | 286,764 | 246,438 | 255,324 | 346,116 | | Cost of Revenue | 172,799 | 154,398 | 152,381 | 212,785 | | | Gross Profit | 113,965 | 92,040 | 102,943 | 133,331 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 74,015 | 72,823 | 75,320 | 100,991 | | Non Recurring | 3,787 | 6,901 | 12,138 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 36,163 | 12,316 | 15,485 | 32,340 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 388 | (430) | 240 | 1,430 | | Earnings Before Interest And Taxes | 36,551 | 11,886 | 15,725 | 33,770 | | Interest Expense | 70 | 209 | 221 | 1,011 | | Income Before Tax | 36,481 | 11,677 | 15,504 | 32,759 | | Income Tax Expense | 9,687 | 3,771 | 5,009 | 8,642 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26,794 | 7,906 | 10,495 | 24,117 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26,794 | 7,906 | 10,495 | 24,117 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26,794 | $7,906 | $10,495 | $24,117 |
|
0.29% Nasdaq 
Income Statement
